When Pam McClure learned she’d save nearly $4,000 on her prescription drugs next year, she said, “it sounded too good to be true.” She and her husband are both retired and live on a “very strict” budget in central North Dakota.
Hemogenyx gets reprieve as FDA lifts clinical hold on AML CAR-T therapy – Pharmaceutical Technology
Share this article The FDA placed a clinical hold on the trial for HEMO-CAR-T in June, requesting additional information from Hemogenyx. Credit: JHVEPhoto via Shutterstock.
February 9, 2024